Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study

Added 533 days ago (12.01.2021)
Authors: Potere, N., Di Nisio, M., Cibelli, D., Scurti, R., Frattari, A., Porreca, E., Abbate, A., Parruti, G.
Read article